ARN-3015

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameARN-3015
Drug Alias Nameserine threonine protein kinase SIK2 inhibitor (Arrien)protein kinase inhibitors (Arrien)ARN-3020ARN-1032ARN-3015
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase SIK2 inhibitorsAnticancer protein kinase inhibitors
TargetsSerine/threonine-protein kinase SIK2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArrien Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArrien Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A